XoNovo Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

XoNovo General Information


Developer of technologies for the treatment of neurodegenerative diseases. The company engages in the development of small-molecule therapeutics for preventing the progressive loss of neuronal function across multiple neurodegenerative diseases, enabling physicians with selective modulation of autophagy and axonal transport machinery in neurons.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Ilan Ramon Street 2
  • Ness Ziona
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XoNovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2019 Completed Out of Business
1. Accelerator/Incubator 12-Jan-2015 Completed Startup
To view XoNovo’s complete valuation and funding history, request access »